FR2939044B1 - NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION - Google Patents

NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION

Info

Publication number
FR2939044B1
FR2939044B1 FR0806692A FR0806692A FR2939044B1 FR 2939044 B1 FR2939044 B1 FR 2939044B1 FR 0806692 A FR0806692 A FR 0806692A FR 0806692 A FR0806692 A FR 0806692A FR 2939044 B1 FR2939044 B1 FR 2939044B1
Authority
FR
France
Prior art keywords
milk
antised
lyophilisates
allergic
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0806692A
Other languages
French (fr)
Other versions
FR2939044A1 (en
Inventor
Dit Bon Michel Betend
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0806692A priority Critical patent/FR2939044B1/en
Priority to ITVR2009A000204A priority patent/IT1396838B1/en
Priority to CH01827/09A priority patent/CH699924A2/en
Publication of FR2939044A1 publication Critical patent/FR2939044A1/en
Application granted granted Critical
Publication of FR2939044B1 publication Critical patent/FR2939044B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FR0806692A 2008-11-28 2008-11-28 NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION Expired - Fee Related FR2939044B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0806692A FR2939044B1 (en) 2008-11-28 2008-11-28 NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION
ITVR2009A000204A IT1396838B1 (en) 2008-11-28 2009-11-26 NEW LIOFILIZED FORMULATIONS OF ASINE MILK AND INHIBITORS OF HUMAN PROTEASES, INDICATED IN MILK INTOLERANCE, ALLERGIC INFLAMMATION AND INFECTIONS
CH01827/09A CH699924A2 (en) 2008-11-28 2009-11-27 Composition, useful e.g. to prepare food supplement, comprises freeze dried donkey milk mixed to lyophilisate of natural inhibitors of human proteases extracted from quail egg white of species (Coturnix coturnix japonica of strain B.mina)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806692A FR2939044B1 (en) 2008-11-28 2008-11-28 NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION

Publications (2)

Publication Number Publication Date
FR2939044A1 FR2939044A1 (en) 2010-06-04
FR2939044B1 true FR2939044B1 (en) 2010-12-31

Family

ID=40847789

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0806692A Expired - Fee Related FR2939044B1 (en) 2008-11-28 2008-11-28 NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION

Country Status (3)

Country Link
CH (1) CH699924A2 (en)
FR (1) FR2939044B1 (en)
IT (1) IT1396838B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1020496A3 (en) 2012-02-10 2013-11-05 Ovogenics Sa ANTI-INFLAMMATORY COMPOSITION FOR MODULATING THE CELLULAR RESPONSE OF NEUTROPHILES AND EOSINOPHILES
ITRM20120170A1 (en) * 2012-04-19 2013-10-20 Dicofarm Spa "FOOD ASINE BASED ON FOOD FORTIFIED FOR PRETERMINE AND / OR FINAL INFANTS WITH ALLERGY OR INTOLERANCE TO VACCINE MILK PROTEINS AND ITS PREPARATION METHOD"
CN110563837B (en) * 2019-08-01 2021-07-30 华中农业大学 Method for efficiently extracting ovomucoid from egg white

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR913241A (en) * 1945-08-08 1946-09-02 Formula milk and its manufacturing process
FR2477017A1 (en) * 1980-02-29 1981-09-04 Lyore Labo Anti:allergic powdered compsns. - contg. quail(s) eggs, protein hydrolysate and hepato-protecting amino acid
FR2621484B1 (en) * 1987-10-08 1991-03-29 Medibrevex NOVEL GALENIC FORMS OF QUAIL EGGS FOR PER- AND SUBLINGUAL ADMINISTRATION IN THE TREATMENT OF ALLERGIC DISEASES AND THEIR PREPARATION METHOD
FR2740041B3 (en) * 1995-10-23 1997-09-12 Pental Corp Sa QUAIL EGG COMPOSITION, AND ITS PHARMACEUTICAL OR COSMETIC USE
DE19922932B4 (en) * 1999-01-28 2006-08-03 Marina Brach Cosmetic preparation and process for its preparation
FR2808444B1 (en) * 2000-05-05 2004-03-26 Francois Ballestra USE OF A FRACTION OF EQUIDE MILK FOR THE MANUFACTURE OF A COMPOSITION HAVING AN INTERHIBITION ACTIVITY OF THE PRODUCTION OF INTERLEUKINE-1 AND COMPOSITION THUS OBTAINED
FR2901137B1 (en) * 2006-05-19 2013-01-25 Dit Bon Michel Betend NOVEL GALENIC FORMS OF NATURAL INHIBITORS OF PROTEASIC ENZYMES, QUAY EGG EXTRACTS ASSOCIATED WITH VITAMINS OR / AND MINERALS, AMINO ACIDS INCORPORATED INTO AN EXCIPIENT.

Also Published As

Publication number Publication date
FR2939044A1 (en) 2010-06-04
IT1396838B1 (en) 2012-12-14
CH699924A2 (en) 2010-05-31
ITVR20090204A1 (en) 2010-05-29

Similar Documents

Publication Publication Date Title
CY2019042I2 (en) OPHTHALMIC COMPOSITIONS AND THEIR USE
DE102004032572A8 (en) Connecting arrangement and contact pin
FR2888850B1 (en) NOVEL ANTI-IGF-IR ANTIBODIES AND THEIR APPLICATIONS
DK1891953T3 (en) Sterile formulations and methods that modify the immune response
DE602005017416D1 (en) MACHINING AND TRANSFER DEVICE
DE602005009957D1 (en) RFID DEVICE AND MANUFACTURING METHOD
DK1751087T3 (en) LEVODOPA DERIVATIVES AND COMPOSITIONS AND APPLICATIONS THEREOF
NO20052054D0 (en) Simplified in / out protocol
DK3207941T6 (en) PROCEDURES AND COMPOSITIONS BASED ON DIPHTHERITOXIN-INTERLEUKIN-3 CONJUGATES
DE502006003077D1 (en) Semiconductor component and laser device
DE602006020254D1 (en) POWER LINE COMMUNICATION DEVICE AND POWER LINE COMMUNICATION PROCESS
NL1032239A1 (en) Sequential field display device and method thereof.
DE602005020202D1 (en) Separate connector and connector device
DK1968990T3 (en) Water-soluble benzoazepine compound and pharmaceutical composition thereof
DE602006013554D1 (en) Endoscope device and communication method used in the device
DE602005015455D1 (en) ORAL CARE COMPOSITIONS WITH POLYASPARTATE
FI20061043A (en) Back care device
DE602005012674D1 (en) IDENTIFICATION AND IDENTIFICATION PROCEDURE
DK1812120T3 (en) Skin-protecting, alkalinity-controlling composition and its use
FR2939044B1 (en) NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION
DK1812072T3 (en) Benzothiazole preparation and its use
DE602006003323D1 (en) PERFLUORAMIDED AND HYDROLYZED MALIC ACID ANHYDRID COPOLYMERS
DE602006015924D1 (en) CONTACTLESS ELECTRODE PAIR MANIPULATION DEVICE AND MANIPULATION METHOD
DE602005003134D1 (en) CARE PRODUCTS
ITPN20050041A1 (en) "MOLDING LINE AND PERFECTED THREADING"

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130731